M Ravid
Impact in
- Nephrology top 5%
- Renal Diseases and Glomerulopathies
- Gout, Hyperuricemia, Uric Acid
-
- Chemotherapy-induced cardiotoxicity and mitigation
- Pericarditis and Cardiac Tamponade
Papers in
-
- Amyloidosis: Diagnosis, Treatment, Outcomes 7
-
- Parathyroid Disorders and Treatments 3
- Renal Diseases and Glomerulopathies 2
- Co-authors
- E Sohar (9 shared papers)J. Shapira (5 shared papers)I Kedar (7 shared papers)J Gafni (2 shared papers)Michael Lishner (2 shared papers)Mark J. Greenwald (2 shared papers)R Lang (2 shared papers)Tamara Reshef (1 shared paper)
In The Last Decade
M Ravid
34 papers receiving 680 citations
Peers
Comparison fields: 5 of 80
- Nephrology 122
- Cardiology and Cardiovascular Medicine 217
- Molecular Biology 402
- Oncology 119
- Hepatology 30
Countries citing papers authored by M Ravid
This map shows the geographic impact of M Ravid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Ravid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Ravid more than expected).
Fields of papers citing papers by M Ravid
This network shows the impact of papers produced by M Ravid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Ravid. The network helps show where M Ravid may publish in the future.
Co-authors
The 25 scholars most cited alongside M Ravid, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1990 | 119 | |
| 2 | 1977 | 89 | |
| 3 | The role of amyloidosis in familial mediterranean fever. A population study. | 1969 | 65 |
| 4 | 2003 | 64 | |
| 5 | 1994 | 60 | |
| 6 | 1970 | 49 | |
| 7 | 1982 | 46 | |
| 8 | Colchicine inhibition of casein-induced amyloidosis in mice. | 1974 | 40 |
| 9 | 1977 | 35 | |
| 10 | Degradation of amyloid by a serum component and inhibition of degradation. | 1982 | 21 |
| 11 | Regression of amyloidosis secondary to granulomatous ileitis following surgical resection and colchicine administration. | 1979 | 21 |
| 12 | Colchicine inhibition of the first phase of amyloid synthesis in experimental animals. | 1976 | 15 |
| 13 | 2009 | 15 | |
| 14 | In vitro synthesis of "amyloid"fibrils from insulin, calcitonin and parathormone. | 1976 | 14 |
| 15 | 1994 | 13 | |
| 16 | 1979 | 13 | |
| 17 | 1976 | 10 | |
| 18 | 1974 | 9 | |
| 19 | 1983 | 9 | |
| 20 | 1993 | 7 |
About M Ravid
M Ravid is a scholar working on Molecular Biology, Nephrology, Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Epidemiology, having authored 34 papers that have together received 766 indexed citations. Recurring topics across this work include Amyloidosis: Diagnosis, Treatment, Outcomes (7 papers), Parathyroid Disorders and Treatments (3 papers), Alzheimer's disease research and treatments (2 papers), Medical Imaging and Pathology Studies (2 papers), Renal Diseases and Glomerulopathies (2 papers), Nail Diseases and Treatments (2 papers), Obesity, Physical Activity, Diet (2 papers) and Trace Elements in Health (2 papers). The work is most often cited by research in Nephrology (122 citations), Cardiology and Cardiovascular Medicine (217 citations), Molecular Biology (402 citations), Oncology (119 citations) and Hepatology (30 citations). M Ravid has collaborated with scholars based in Israel and Italy. Frequent co-authors include E Sohar, J. Shapira, I Kedar, J Gafni, Michael Lishner, Mark J. Greenwald, R Lang, Tamara Reshef, Yehuda Ben‐Shaul and Yehuda Shoenfeld. Their work appears in journals such as Cancer, Annals of Internal Medicine, American Journal of Obstetrics and Gynecology, Annals of the Rheumatic Diseases and Lara D. Veeken.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.